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Selected abbreviations and definitions 
CO   cardiac output
cTnI                           cardiac troponin I 
Hb   haemoglobin 
hypoxaemia  deficient oxygenation of arterial blood 
hypoxia  oxygen supply decreased relative to metabolic demand 
FiO2   fraction of inspired oxygen 
LV   left ventricle 
LVP   left ventricular pressure 
MMP   matrix metalloproteinase 
ORAC   oxygen radical absorbance capacity 
PAP   pulmonary artery pressure 
PaCO2   arterial carbon dioxide tension 
PEEP   positive end expiratory pressure
PVR   pulmonary vascular resistance 
ROS   reactive oxygen species 
RV   right ventricle 
RVP   right ventricular pressure 
SBP   systemic blood pressure 
SDE   strain Doppler echocardiography 
TDI   tissue Doppler imaging  
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Introduction
Definition of asphyxia 
Asphyxia is a Greek term and means loss of pulse (1). There is no clear definition of the term, 
though perinatal asphyxia or birth asphyxia often is defined as impaired placental- or 
pulmonary oxygen delivery to the neonate. As a consequence the neonate is going through a 
period of hypoxaemia and hypercapnia with a subsequent respiratory and metabolic acidosis 
(1). In clinical work, the diagnosis of perinatal asphyxia predominantly is based on its 
consequences, and there is a general agreement that a combination of perinatal stress (i.e. fetal 
bradycardia, acidosis, low Apgar scores), multiple organ affection and neurological symptoms 
(i.e. hypoxic ischemic encephalopathy) are required for the diagnosis (2).
Cardiac abnormalities in perinatal asphyxia
Myocardial performance may vary subsequent to asphyxia. The cardiac dysfunction is often 
underdiagnosed and requires a high index of suspicion to detect (3;4). The clinical picture 
varies from brady- or tachycardia to cardiogenic shock (1;5).
Myocardial failure subsequent to asphyxia was first reported in 1961(6). The authors 
described a group of asphyxiated neonates with left ventricular (LV) heart failure within the 
first 24 hours of life. A decade later three term infants were reported with a syndrome of acute 
LV failure accompanied by cyanosis and pulmonary and systemic venous congestion (7). 
Rowe et al (8) classified the cardiac abnormalities following asphyxia in 1978, broadly as: 
 1) Transient myocardial ischaemia of the newborn 
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 2) Transient mitral regurgitation of the newborn 
 3) Transient tricuspid regurgitation of the newborn 
 4) Persistent pulmonary hypertension of the newborn 
Increased pulmonary artery pressure (PAP) and tricuspid regurgitation is the most common, 
and although the cardiac abnormalities were described as separate clinical entities, it is 
important to understand that the distinction may not be clear, and there is much overlap in the 
pathogenesis. In severely asphyxiated neonates post-mortem autopsies have showed ischemic 
papillary muscle necrosis and diffuse subendocardial left ventricular (LV) necrosis secondary 
to perinatal asphyxia (9;10). 
Aetiology
The aetiology of asphyxia in the newborn is multifactorial, including abruption or infarction 
of the placenta, excessive uterine contraction, fetal or maternal bleeding, and compression of 
the umbilical cord. Infection is contributing to its severity, and the clinical picture in severe 
asphyxia may present similar to what is seen in severe congenital heart disease, thus it is 
mandatory to evaluate these neonates by echocardiography to exclude congenital heart 
disease.
Myocardium in the newborn 
At birth the haemodynamic situation changes rather abruptly from a dominating high pressure 
right ventricular (RV) and low pressure LV system to an adult system with low pressure RV 
and high pressure LV (11;12). The RV is dominating in the fetal myocardium (11;13), and the 
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RV stroke volume is greater than of LV (14-16). It is thought that RV performs the majority 
of ventricular work during fetal life (11;12), and RV end-diastolic volume is larger than in 
LV. The RV dimensions are larger, and the curvature of the RV free wall is greater than of 
LV (17;18). Consequently, at birth RV systolic wall stress is greater than in LV, with a greater 
sensitivity to increased afterload of the RV (19). The myocardial work performed by left and 
right ventricle is changing oppositely after birth (20). LV work increases due to the enhanced 
LV stroke volume, systemic blood pressure (SBP), wall tension, and increased systemic 
vascular resistance, whereas RV work falls in association with the decrease in pulmonary 
vascular resistance (PVR) and PAP (21).
The growth of LV and RV is different postnatally (22). The circulatory changes at birth affect 
ventricular size, though the total dimension of the heart stays constant. LV weight and wall 
thickness increase relatively to body weight, whereas RV weight and wall thickness decrease 
over the  first two days of life (23), eventually resulting in an equalization of ventricular size 
postnatal (24;25). The myocardium is thought to grow by cell division in fetal life, and by cell 
growth postnatally (26). The fetal RV myocytes are larger than the LV myocytes and the 
capillary lumen is greater (27). The differences in LV and RV myocytes reverse postnatal, as 
the LV work load increases (20). 
In the myocytes, troponins and tropomyosin constitute the regulatory contractile protein of the 
thin filament of muscle myofibrils, which regulate the calcium-concentration-dependent force 
development of the myofilaments. The troponin complex exists in a group of three subunits, 
troponin I (cTnI), troponin T and troponin C. Troponin T binds the troponin complex to 
tropomyosin. Troponin I and C are located at the troponin T carboxyl terminus. CTnI is the 
actomyosin ATPase inhibiting subunit. There are however, several isoforms of the troponins. 
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Slow skeletal muscle troponin I is synthesized in the fetal myocardium, and the isoform is 
persistent until 9 months of age (28).  
Until a certain degree the Frank-Starling mechanism characterised by the greater preload, the 
greater force of contraction, is found in the fetal and neonatal heart as well as the adult heart 
(29). The fetal and neonatal myocardium, however, is thought to work near the top of the 
Frank-Starling curve close to the “break point”.  The neonatal myocardium can only increase 
stroke volume to a small degree in response to an increase in preload (30;31). The sarcomere 
length and the extent of overlap between the thin and thick filament during contraction is 
crucial to the process of force development and contraction. It is, however, not the length 
itself, but the spacing between actin and myosin filaments that sets the level of Ca++
sensitivity (32;33). 
In an animal model, it has been shown that oxygen consumption is approximately 40% higher 
in the neonatal compared to fetal and adult myocardium (34). The neonatal myocardium has 
greater myocardial glycogen stores (35;36), and glucose and lactate is thought to be the 
primary source metabolized in the immature myocardium (34). In the fetus this may be due to 
a deficiency in the enzyme carnitin palmitoyl transferase-l, responsible for transporting long-
chain fatty acids into the mitochondria (37). Glucose ameliorates the effect of prolonged 
hypoxaemia in both fetal and adult heart (36). 
Circulation in the newborn
At birth the circulatory system has been changed from a parallel to a serial circuit, and the gas 
exchange has been transferred from the placenta to the lungs. An adequate pulmonary 
circulation has been established, and the three fetal intra- and extra-cardial shunts; ductus
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arteriosus, foramen ovale, and ductus venosus are gradually closed (38). The cardiovascular 
transition at birth has been instituted by the pulmonary physical expansion, ventilation, and 
increased oxygen tension subsequent to the first breath (39;40). The factors promoting 
vasoconstriction have been downregulated while the vasodilating mechanisms have become 
instantly operative. Accordingly, the pulmonary arteries and veins have been relaxed in 
response to endothelin-derived nitric oxide and dilatory prostaglandins, assisting the fall in 
pulmonary vascular resistance (PVR) (41). Pulmonary blood flow has rapidly been increased 
and the umbilical-placental circulation discontinued, gradually resulting in a circulation with 
equal left and right ventricular output in series.
At the onset of breathing, PVR decreases with a concomitant increase in pulmonary blood 
flow (39;42;43). Accordingly, as the pulmonary venous return increases, left atrial pressure 
exceeded right atrial pressure and foramen ovale is being functionally closed. By the first 24 
hours of age the mean pulmonary artery pressure (PAP) has fallen below the mean SBP in 
most human infants, and by three days mean PAP in healthy human infants has been shown to 
be less than 50 % of the mean systemic blood pressure (SBP) (44;45). The rearrangement of 
circulation with closure of the fetal shunts contributes to the increase in LV preload and thus 
stroke volume. RV systolic pressure decreases while LV systolic pressure increases. Both 
ventilation, oxygenation, and umbilical cord occlusion contributes to a progressive shift in the 
LV and RV outputs (39;46). With the cessation of the placental circulation, the large placental 
run-off has been interrupted, with a concomitant increased systemic vascular resistance. LV 
output has been markedly enhanced and RV output increased to a smaller extent 
(15;16;47;48) equalising the LV output as the foramen ovale and ductus arteriosus have been 
closed (40;42).
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Hypoxaemia-reoxygenation injury 
In general, myocardial reoxygenation/reperfusion injury subsequent to hypoxaemia and/or 
ischaemia includes cardiac contractile dysfunction (49), arrhythmias (50) and reversible or 
irreversible myocyte damage including both apoptotic and necrotic cell death (51). The 
myocardial injury is associated with release of reactive oxygen species (ROS) and 
inflammation (52). In the hypoxaemic newborn, however, both physiological as well as 
cellular- and molecular mechanisms have to be addressed. 
Hypoxic pulmonary vasoconstriction 
The pulmonary circulation constricts in response to acute hypoxaemia, which is reversible on 
reexposure to oxygen (53;54). Severe pulmonary vasoconstriction as well as relaxation of 
ductus arteriosus are induced by the hypoxanthine-xanthine oxydase system forming ROS 
(55;56), and there has been found a relation between low alveolar oxygen tension and 
increased PVR (57). In the newborn, these haemodynamic changes following hypoxaemia 
have to be considered and kept in mind during tissue analyses and assessments of myocardial 
performance (58;59). The pulmonary vasculature is regulated by different mechanisms, 
including nitric oxide (NO) derived from the endothelium, reactive oxygen species generated 
by mitochondria, changes in intracellular K+, Ca2+, and H+ concentrations as well as 
prostacyclin, prostaglandin E2, and bradykinin (53;60;61). Despite extensive characterization 
of the structural and functional changes occurring in pulmonary vasculature in response to
hypoxaemia, the exact cellular mechanisms underlying hypoxaemic pulmonary
vasoconstriction remain poorly understood (62).
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ROS
There is growing evidence that oxidative stress and ROS formation are involved in 
hypoxaemia/reoxygenation/reperfusion injury (63-65), and antioxidant treatment has been 
shown to protect myocardium against reperfusion injury (66). ROS are reactive redox 
intermediates produced during the sequential reduction of molecular oxygen. ROS fall into 
two groups; those that contain unpaired electrons (O2
-, OH-), or those that have the ability to 
extract electrons from other molecules (H2O2, HOCl). These species may damage 
biomolecules directly, or initiate chain reactions in which ROS are passed from one molecule 
to another, resulting in extensive damage to cell structures such as membranes and proteins 
(67). A rapid and transient burst of huge amounts of ROS are described with the first 
moments of reperfusion (68). ROS may be generated as a result of high oxygen concentration 
(69-71). Paradoxically, there are also described protective effects of ROS, and biological 
tissues have substantial ability to tolerate ROS under normal conditions (68;72). Living 
organisms have not only adapted to protect against ROS, they have also developed 
mechanisms for the beneficial uses of free radicals (68). ROS can be preventive as signal 
preconditioning protection, and induce stress responses that lead to survival (72). 
In the setting of hypoxaemia/ischaemia and subsequent reoxygenation/reperfusion, however, 
the antioxidant defences are eroded and this carefully orchestrated homeostasis is altered 
(68;73). Tissues have several endogenous ROS scavenger systems to combat the cytotoxic 
actions of ROS, including enzymes as superoxide dismutases, gluthation peroxidases, and 
catalases, large molecules as albumin, small molecules as ascorbic acid, glutathtion, uric acid, 
and carotenoids (74). During pathological conditions as hypoxia and acidosis, tissues have 
increasing capability of generating the destructive hydroxyl radical (.OH). Hydroxyl radicals 
are extremely reactive and may cause direct cell membrane damage, lipid peroxidation, and 
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damage to proteins and sulfhydryl bonds (68). ROS is associated with inflammation and 
cytokine release by upregulation of matrix metalloproteinases (75-77), hence ROS act as 
mediator of cell injury and myocardial dysfunction (63-65).
Matrix metalloproteinases
Matrix metalloproteinases (MMPs) belong to a family of zinc and calcium dependent 
endopeptidases involved in varieties of physiological and pathological processes through the 
turnover of the extracellular matrix (78;79). There are four subgroups of MMPs, according to 
which components of the extracellular matrix they degrade, the collagenases (MMP-1, MMP-
8 and MMP-13), the gelatinases (MMP-2 and MMP-9), the stromelysins (MMP-3, MMP-10 
and MMP-11), and the membrane-type MMPs, which may both activate other MMPs and 
degrade various extracellular matrix components (65). MMPs are important in normal 
physiological processes as embryogenesis and wound healing (80), and are also involved in 
pathological conditions such as tumour metastasis (79) and cardiac remodelling (81). 
In healthy tissue MMP activity normally is low, and the MMPs are tightly regulated at both 
transcriptional level through control of the activation of the latent enzymes, and through 
inhibition by specific endogenous tissue inhibitors of metalloproteinases (TIMPs) (82). 
During pathological conditions the zymogens can be activated by proteolytic cleavage (78), or 
stepwise by low pH (83), oxidative stress (84-88), and during inflammation (49;75;77). 
MMPs are thought to act as signalling proteinases, and activation may occur within seconds to 
minutes (89). Increased MMP-levels reflect illness, and during acute myocardial ischaemia 
and subsequent reoxygenation different MMPs are involved (65;90).
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In a human study of term and preterm neonates, plasma level of MMP-2 and MMP-9 was 
found to be gestational dependent, with the highest levels at 33-36 weeks of gestation (91). 
MMP-2 and MMP-9 were lower in term neonates as in preterm babies with earlier gestational 
age. MMP-9 showed a 50% decrease the first postnatal month, while MMP-2 was stable in 
the first month after birth (91). Accordingly we would have expected steady levels of the 
assessed MMPs in healthy neonates not suffering from asphyxia.  
Resuscitation of the newborn 
According to World Health Organization resuscitation is estimated to be needed in 
approximately 3-7 % of newborn infants to establish a vigorous cry or regular respiration, 
maintain a heart rate >100 beats per minute and achieve good colour and tone (92;93). 
Resuscitation procedures vary worldwide from gentle stimulation to more vigorous treatment 
(94;95). Even though mouth-to-mouth breathing was practised hundreds of years ago by 
midwives to revive stillborn infants, it fell out of fashion in the 18th century as Dr Hunter, an 
enormously influential obstetrician, declared it “a vulgar practice” (95).  
Resuscitation in the newborn is different from resuscitation in other groups of age, and 
knowledge of relevant physiology and pathophysiology is essential. In contrast to adults, 
neonates usually have a beating heart during resuscitation, though heart rate and cardiac 
output may be severely depressed. Bradycardia is in most cases caused by hypoxaemia 
(96;97), and the tendency of apnoea induced by upper airway stimulation is enhanced by 
hypoxaemia (98-100). Ventilatory rate is normally increased by hypoxaemia, which 
stimulates pulmonary stretch receptors with a concomitantly reduced vagal tone and increased 
heart rate (99;101). Accordingly, the major importance is to emphasize ventilation, and ensure 
adequate inflation of the lungs to reverse hypoxia, acidosis, and bradycardia (93;97;102;103). 
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Airways should be cleared and opened before ventilation is started. However, care must be 
taken as laryngeal suctioning and unsuccessful attempt of intubation may aggravate both the 
apnoea and the bradycardia (93;98). Severe asphyxia may eventually cause cardiac arrest, and 
cardiac compressions should be started if heart rate remains low (less than 60 beats per 
minute) despite adequate ventilation for 30s. The most efficient way is to encircle the chest 
with both hands with the thumbs opposed on sternum just below the inter-nipple line. Current 
recommendations are a 3:1 ratio with 90 compressions and 30 breaths per minute at a rate of 
120 events per minute to achieve approximately 90 compressions and 30 breaths per minute. 
Drug therapy should be considered if there is no response in heart rate after 30 sec of 
combined ventilation and chest compression (93;97). Hypovolemia should be suspected if the 
neonate does not respond to resuscitation, and treatment with volume expansion may be 
needed. An isotonic crystalloid solution is recommended as volume expander. If replacement 
of large blood volume loss is necessary, O-negative red blood cells is indicated (93). Heat loss 
should be prevented as oxygen consumption is increased by cold stress and may impede 
effective resuscitation. 
Until recently, 100% oxygen has been recommended during resuscitation of asphyxiated 
newborn infants (104). Over the last few years, however, there has been growing evidence 
that ambient air may be as efficient as 100% O2 (105-107). Regarding the latest guidelines of 
resuscitation of newborn, the goal of supplemental oxygen use is normoxia (93;108), and 
ambient air resuscitation of asphyxiated neonates is recommended when availability of 
oxygen is limited (93;109).  
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Treatment strategies 
Ventilation
Little evidence-based data have been available regarding optimal resuscitation methods of 
newborn, and questions have been raised to improve treatment strategies and performance of 
resuscitation (110;111). Establishment of adequate ventilation is of primary concern (93), and 
bag/mask-ventilation performed by the experienced is thought to be satisfactory in 80% of the 
resuscitated infants. Endotracheal intubation is needed in only 20% or less (112). The initial 
inflation of the fluid-filled lungs need higher opening pressure and inspiratory time than the 
subsequent breaths of the newborn (102;113). When functional residual capacity is optimised, 
end-expiratory airway pressure can be decreased without a great loss of lung volume as long 
as the pressure is not decreased below the critical closing pressure of the lung (114). Positive 
end expiratory pressure (PEEP) is thought to be important for neonatal ventilation. Using 
PEEP during resuscitation has shown to improve compliance of the respiratory system without 
any differences in arterial carbon dioxide tension (PaCO2) (115). A PEEP level of 5 mmHg 
during ventilation of children demonstrated elevated cardiac index and stroke volume index 
compared to higher levels of PEEP (116). There are, however, still insufficient data to 
determine the safety and efficacy of PEEP during neonatal resuscitation (117).  
Also initially, during the first positive pressure breaths administered during resuscitation, 
harmful ventilation may cause severe pulmonary disease in newborn as a result of 
‘barotrauma’ (implying injury caused by pressure), ‘volutrauma’ (implying injury caused by 
excessive tidal volume delivery), and/or ‘atelectrauma’ (implying injury caused by alveolar 
collapse) (118-120). Hyperventilation in infants with persistent pulmonary hypertension is 
associated with poorer neurodevelopmental outcome (121). In animal models it has been 
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shown that hyperventilation may be detrimental during resuscitation, probably as a result of 
increased intrathoracic pressure causing considerably decreased coronary perfusion pressures 
(122;123).
Oxygen
Oxygen as a separate gas was recognized in the late 18th century, independently discovered by 
the Swedish pharmacist Karl W. Scheele and the English chemist Joseph Priestly. Oxygen 
was described as a necessary but dangerous substance, essential for multicellular life. The first 
experiments on humans are said to have been made by Chaussier in 1783, giving oxygen to 
infants suffering from asphyxia, and to dyspnoeic patients with phthisis (124). Ventilation-
perfusion mismatch and diffusion impairment were described as a cause of hypoxaemia in the 
early 20th century (54;125;126), and administration of oxygen became routine to patients with 
acute and chronic lung disease observing improved lung function. Oxygen was regarded as a
medicine. Oxygen supply for neonatal resuscitation was not recommended before the 20th
century (95). Since then oxygen has been one of the most commonly used therapies in the 
neonatal intensive care unit (127).
Soon after its discovery, however, oxygen was acknowledged as potentially poisonous. 
Oxygen was considered to be “a good thing”, though it was possible to have “too much of a 
good thing” (124). In the early 1950’s the first observations regarding excess oxygen resulting 
in retrolental fibroplasia were reported (128;129), and investigation in oxygen has since then 
generated considerable information regarding both physiological and toxic effects of oxygen.
Molecular oxygen is a major source generating ROS. Mitochondrial electron transport 
reduces 95% of O2 to H2O without any free radical intermediates; the remaining 5% of 
21
oxygen however, is reduced producing free radicals. Oxygen toxicity is mainly believed to 
result from ROS formation. When ROS generation is in excess of antioxidant defence 
mechanisms, the condition can be defined as oxidative stress. Biological cells maintain a 
delicate balance between the protective oxidant signalling versus detrimental effects and this 
balance seems a critical aspect of aerobic life (68). 
Despite decades with research in both human and animal models, there is still an ongoing 
debate and no consensus regarding the optimal concentration of oxygen supply for neonatal 
resuscitation.  
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Aims of the study 
Resuscitation after birth is a common procedure, and it is important to develop optimal 
resuscitation methods to prevent additional iatrogenic injury. Over the last few years, there 
has been growing evidence that ambient air is as efficient as 100% O2 (105;130;131). Little 
attention has, however, been paid to whether ventilation frequency or modus operandi of
resuscitation influences the outcome of the newborn. Myocardial function and circulation are 
important during and after resuscitation of the asphyxiated newborn. We therefore focused on 
myocardial injury and performance during hypoxaemia and subsequent reoxygenation in a 
model of newborn pigs subjected to severe hypoxaemia.  
1)  A) Is myocardial injury after hypoxaemia and subsequent reoxygenation assessable by 
clinically well established blood tests (cTnI, CK-MB, myoglobin) in newborn pigs?  
B) Does reoxygenation with 21% or 100% oxygen at different PaCO2 levels or 
ventilatory mode during reoxygenation influence myocardial injury as assessed by 
cTnI, CK-MB, and myoglobin? (Paper I) 
2)  Does severe hypoxaemia cause haemodynamic changes in newborn pigs assessable by 
conventional Doppler echocardiography, and is outcome different if reoxygenation is 
performed with 21% or 100% oxygen? (Paper II) 
3)  Are there any differences in myocardial tissue injury as assessed by matrix 
metalloproteinases and endogenous antioxidant capacity in myocardial tissue extracts 
subsequent to reoxygenation with 21% or 100% oxygen at different PaCO2 levels in 
hypoxaemic newborn pigs? (Paper III)  
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4)  Is myocardial left ventricular performance in hypoxaemic newborn pigs assessable by 
strain Doppler echocardiography, and is it necessary to evaluate left ventricular 
function by differentiating between longitudinal and radial contraction in newborn 
pigs during hypoxaemia? (Paper IV) 
24
Methodological considerations
The animal model 
Animal models will always be an approximation of the clinical situation of interest. There 
may be important differences between the model and the clinical situation that should be kept 
in mind when results are interpreted. Nevertheless, animals are extensively used in biomedical 
research in an attempt to understand the mechanisms of disease using methods not available 
in clinical research. There are, however, some ethical dilemmas performing animal research, 
such as the importance of avoiding painful procedures of the experimental animal. The 
justification of taking the life of other species should always be considered when new 
experiments are planned. Nevertheless, when studying complex integrative physiology where 
the number of unknown variables influencing the responses studied is large, at present there is 
no alternative to animal experiments.  
In the present studies newborn Landrace pigs of either sex (12-36h) were exposed to 
hypoxaemia by ventilation with 8% O2 in N2 until either mean arterial blood pressure (MAP) 
decreased to 15mmHg or BE d -20mmol/L. Mean hypoxaemia time was 60 min. The pigs 
were then reoxygenated with either 21% or 100% oxygen for 30min. In paper I/III each of 
these major groups were divided into three subgroups during reoxygenation, and ventilated at 
different PaCO2-levels (Fig 1). Subgroups A1/B1 were hyperventilated, PaCO2 2.0–3.5 kPa. 
Subgroups A2/B2 were normoventilated, PaCO2 4.5–6.0 kPa, and subgroupsA3/B3 were 
normoventilated and added CO2 gas to reflect hypercapnia, PaCO2 8.0-9.5 kPa. The pigs were 
then observed and ventilated with ambient air and normal PaCO2 4.5–6.0 kPa. 
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Fig 1: Time course during resuscitation.
The pig as an experimental animal 
We used a porcine model, because newborn pigs resemble humans in anatomy and 
physiology of the cardiovascular system (132;133). In addition to the size and morphological 
characteristics, there are physiologic similarities in the areas of coronary blood flow (134), 
growth of the cardiovascular system, and neonatal pulmonary development (133).  
There are, however, some differences. The porcine pericardium is attached to the sternum, 
and the apex of the heart is in close opposition to the diaphragm. Myocardium in newborn 
pigs is delicate and especially susceptible to arrhythmias. Care must be taken to avoid 
adrenergic stimulation by stressing the pigs (133).  
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Another difference that may influence haemodynamics is haemoglobin (Hb) level between 
human and pigs. Normal Hb in newborn babies the first day of life is approximately 18.5g/dL 
(135). In her thesis Egeli found mean Hb 7.9 g/dL in newborn pigs (136), and in newborn pigs 
there has been found an inverse relationship between CO and Hb levels (132). At birth human 
infants mostly have fetal Hb, while Hb in newborn pigs resembles adult Hb (137). The lower 
Hb level may partly be compensated for by a higher oxygen extraction fraction. In our 
experiment there were no differences between the groups examined and compared. The 
newborn pigs examined in paper I/III had Hb 7.7 g/dL (± 1.5), and in paper II/IV Hb was 6.8 
g/dL (± 1.2). These are slightly beneath normal values in newborn pigs, and there were no 
difference in Hb between groups of pigs compared in the thesis.  
Anaesthesia
The use of anaesthesia is a problem in animal research, as it will affect the results, 
complicating interpretation and comparison of previous experiments. There is, however, 
unethical to perform animal experiments without adequate anaesthesia. On the other hand, 
pigs are easily stressed, and pain and anxiety in the experimental animals would also affect 
the results by adrenergic stimulation and not reflect the true resting situation.
In the present work anaesthesia was induced by halothane mixed with ambient air and 
oxygen, and was discontinued when an ear vein was cannulated usually within two-three 
minutes. Fentanyl, Midazolam, and pentobarbital sodium was then titrated and given as bolus 
injections. Local infiltration of lidocain in the skin was given before tracheostomy was 
performed, and anaesthesia was thereafter given as a continuous infusion of fentanyl 25-50 
µg/kg/hour and midazolam 0.25mg/kg/hour. One bolus of pancuronium was given before the 
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surgical preparations. Depth of anaesthesia was monitored by response to painful stimuli 
elicited by pinching of the nasal septum in addition to standard monitoring of heart rate and 
blood pressure. Additional fentanyl was given if necessary. At the end of the experiment, the 
pigs were given an overdose of 150 mg/kg pentobarbital intravenously.
In the present work we tried to use anaesthetics recommended and preferred for cardiac 
procedures (133;138). The medication used to induce anaesthesia, however, has dose-
dependent effects on the cardiovascular system. Both halothane and pentobarbital were given 
in low doses, and was usually discontinued for approximately two hours prior to the 
experiment as a consequence of time for instrumentation and stabilisation, thus we regard the 
effect of these medications to be minor or ignored. The effects of halothane are dose related 
and dose dependent. Halothane has a potential cardiovascular depressive effect, and may 
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depress myocardial contractility and myocardial metabolic activity as a result of inhibition of 
glucose uptake in myocardial cells. Halothane may reduce cardiac output (CO) and decrease 
mean arterial blood pressure, while it causes no change in systemic vascular resistance. 
Arrhythmias may occur, both bradyarrhythmias caused by central vagal stimulation and 
tachyarrhythmias associated with increased excitability augmented by hypercapnia, 
hypoxaemia or circulating catecholamines (133;138).
Pentobarbital 50mg/ml was titrated in doses of 10mg until tracheostomy was performed, and 
then discontinued. Pentobarbital is recommended used as pig anaesthesia, though it may cause 
respiratory depression, decreases myocardial contractility and CO, and increases peripheral 
vascular resistance (133).
Fentanyl is an opioid and has minimal cardiovascular effects. Fentanyl has no direct effects on 
heart, hence there is no change in contractility, automaticity (though increased vagal activity), 
conduction, or sensitivity to catecholamines. Bloodflow autoregulation in heart is preserved. 
Combined with other hypnotica bradycardia or hypotension may occur (133;138).
Midazolam is a benzodiazepine with mild cardiovascular effects. Midazolam may slightly 
reduce systemic arterial blood pressure, and to a lesser degree decrease cathecolamin release 
and increase coronary blood flow. Combination of benzodiazepines and opioids are 
recommended for cardiac investigation. If combined with opioids in larger doses, however, 
midazolam may cause cardiodepression (133;138).  
Pancuronium is a muscle relaxation given only once as a bolus of 0.1mg/kg before the initial 
surgical procedures. Pancuronium has a slight effect on cardiovascular system (133;138). 
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Surgical setup and invasive pressures 
The experimental animals were exposed to miner surgery, but it may nevertheless influence 
outcome. Both tracheostomy and insertion of catheter in the femoral artery measuring blood 
pressure occasionally injured striated muscle, which probably affected the blood tests (CK-
MB, myoglobin). In the pigs referred to in papers II /IV there were inserted a catheter for 
measuring central venous pressure in left external jugular vein, and a Millar catheter in LV 
through the left carotid artery, assessing left ventricular pressure (LVP) and calculating LV 
dP/dt from the LVP curves. The Millar catheter is known to be prone to drifting. This is, 
however, a result of protein deposits or a film covering the micro manometer pressure sensor 
of the catheter. To minimise drift, the catheter was cleaned immediately after us, the pressure 
sensor was pre-soaked in tempered (38°C) saline for 30 minutes prior to calibration, and the 
catheter was used as recommended by the manufacturer (139).  
Though we allowed a period of recovery after the initial procedures and care was taken to 
minimise myocardial damage, baseline measurements may probably be impaired compared to 
healthy non-instrumented pigs. 
Blood and tissue analyses
CTnI, CK-MB, myoglobin 
Cardiac Troponin I (cTnI) has been established as a sensitive and specific marker of 
myocardial injury both in humans and pigs (140-142), with no increase in serum subsequent 
to acute or chronic skeletal muscular disease (143). In human neonates, cardiac troponin is 
unaffected by gestational age, birth weight, sex and mode of delivery (140;144). CTnI has 
been suggested as a new “golden standard” in paediatric patients (145), even though 
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comparing measured cTnI values between different studies are difficult because of variations 
in sensitivity and specificity of commercially available cTnI diagnostic immunoassays kits 
(146-148). In the thesis the analyses of cTnI were performed by two different immunoassays, 
none of them cross reacting with cardiac troponin T or slow skeletal muscle troponin I. The 
different immunoassays, however, implies that cTnI values in paper I/III and paper II/IV are 
not directly comparable.  
CK-MB (creatine kinase-myocardial band) has high specificity and was earlier used as “gold 
standard” for the diagnosis of myocardial infarction. Soldin et al found CK-MB proteins more 
pronounced in healthy term neonates than in adults (149), and during fetal and neonatal 
development, the B-subunit is found to be the predominant CK species produced by skeletal 
muscle (143). CK-MB has been used as an early (<6 hours) marker of acute (myocardial) 
muscular injury (150). Myoglobin is predominantly a cytosolic protein found in striated 
muscle, and there is no difference between isoforms found in myocardium compared to 
skeletal muscle (151). Several authors have found myoglobin and CK-MB as less sensitive 
and specific markers of myocardial injury than troponin (149;152;153) which is consistent 
with our results (154). 
Matrix metalloproteinases 
Matrix metalloproteinases (MMPs) are markers of myocardial tissue injury reflecting illness 
(65;155). Myocardial MMP-activity has been correlated with cardiac functions in humans 
(52), and inhibition of MMP-activity has been shown to significantly improve cardiac 
functions during reperfusion subsequent to ischaemia (156). During acute myocardial 
ischaemia and subsequent reoxygenation different MMPs are involved (90). MMP-1, 2, and 9 
appear to be of especially importance as they are differently generated and most likely 
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responsible for alternative aspects of the pathological processes in myocardium (65). Raised 
MMP-1 levels secondary to myocardial infarction is thought to predict subacute LV 
remodelling (157), while enhanced levels of MMP-2 and 9 have been associated with 
reperfusion injury after ischaemia contributing to cardiac mechanical dysfunction in different 
experimental models (158-160). MMP-2 has demonstrated intracellular activity by cleaving 
cTnI from the troponin complex (156), and may also be released by platelets activated during 
ischaemia (89;161). Thus MMP-2 may contribute to myocardial cellular injury as well as 
impaired myocardial contractility. Recently in a resuscitation model of hypoxaemic newborn 
pigs (162) MMP-2 was found increased and probably activated because of oxidative stress, in 
agreement with observations in our study (163).  
In the previous study, we have analysed MMPs in myocardial tissue extracts by two different 
methods. Broad matrix degrading capacity is the analysis of the joint capacity of MMP-1, 
MMP-2 MMP-7, MMP-8, MMP-9, MMP-12, and MMP-13 referred to as “total MMP 
activity”, using a fluorogenic peptide substrate. In gelatine zymography, the MMPs are 
identified by the capacity of degrading gelatine after electrophoresis. The MMPs are 
identified by molecular weight. MMP activity is detected as clear bands against a background 
of undegraded substrate. Incubation with EDTA was used as a control demonstrating that the 
metal-dependent lysis zones were the result of gelatinase activity. One tissue sample and a 
human standard were used as internal controls on every zymogram. 
Endogenous antioxidant capacity
The oxygen radical absorbance capacity (ORAC) assay measures free radical scavenging 
activity against ROS in tissue samples, the total antioxidant capacity. Antioxidant capacity is 
defined as the ability of a compound to reduce pro-oxidants. Several compounds are 
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considered to act in a concerted way providing antioxidant defences to the organism, 
protecting against harmful effects of ROS (64;164). There are also several combinations of 
internal and external antioxidants and the radicals they combat. This might explain why no 
single measure of antioxidant status is going to provide a sufficient amount of data to evaluate 
in one assay the free radical scavenging activity of a tissue sample.
The ORAC assay utilises a biological relevant radical source and measures the protective 
effect of antioxidants as the capacity of the tissue sample to directly quench free radicals. 
Trolox, a water-soluble vitamin E analog, is used as the calibration standard and the ORAC 
result is expressed as micromole Trolox equivalent (TE) per gram tissue. 
ORAC is the only method combining both percentage degree of inhibition and inhibition time 
of free radical action by antioxidants into a single quantity (74). The ORAC assay has high 
specificity, and provides significant information regarding the antioxidant capacity of 
biological samples (165;166). The ORAC method is sensitive and has several advantages in 
comparison to other commonly used methods, as it gives more information of the in vivo 
situation in tissues (74). Regardless of the source of oxygen-derived free radicals, cellular 
injury may occur during reperfusion if the level of oxidative stress exceeds the capacity of 
endogenous free radical scavenging mechanisms (167). As the total endogenous antioxidant 
capacity decreases, the protective mechanisms against oxygen toxicity is reduced (168), thus 
describing a considerable creation and consumption of ROS implying oxidative stress in the 
tissues (84;168;169). 
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Doppler echocardiography 
The Austrian physicist Christian Johann Doppler first hypothesised “the Doppler effect” in 
1842, the phenomenon when a source and receiver are moving relative to each other, and the 
perceived frequency of any kind of wave is altered. For measuring blood flow velocity, an 
ultrasound transducer is both the wave source and receiver, whereas red blood cells are the 
moving targets that alter or “shift” the received frequency depending on their velocity and 
direction (170;171). Ultrasound is acoustic waves with a frequency above the audible range. 
For diagnostic purposes, frequencies in the range of 1-15 MHz are used. The first use of a 
Doppler method for detection of cardiac motion was described by Yoshida et al (172). 
Technology has improved considerably over the last decades, and today Doppler ultrasound 
and two-dimensional echocardiography are the main tools in routine investigation and follow-
up newborn with circulatory disturbances and/or congenital heart disease (171;173).
We used a Vivid 7 digital ultrasound scanner (GE VingMed Ultrasound, Horten, Norway) 
with an integrated program for quantitative analysis (software version 2.2.0 EchoPAC GE 
Vingmed). The transducer was a combined tissue imaging and Doppler transducer (10S) with 
a frequency range from 4.0 to 12.0 MHz. The recordings were mainly obtained using the 
factory default 8.9 MHz. Hair in front of the chest was removed prior to the examinations. 
Two investigators, one handling the probe and one operating the scanner performed all 
ultrasound standard examinations (132;174). The data were sampled when both investigators 
agreed that the imaging quality was optimal. The accuracy of Doppler velocimetry is affected 
by the angle between the ultrasound beam and blood flow, thus for each view care was taken 
to keep the Doppler beam oriented as parallel as possible to the direction of motion (175).  
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The first examination was performed to exclude congenital heart defects with the pigs lying in 
a right lateral, half supine position. The aortic valve diameter was measured from 2D
parasternal long-axis views from inner edge to inner edge at the base of the aortic valve 
leaflets (176) before guiding the intrusion of the Millar catheter. The aortic valve diameter 
was later used for all calculations of cardiac output (CO). Further studies were performed with 
the pigs lying in a left lateral, half supine position. CO was calculated from aortic flow as 
systolic velocity integral x valve area x heart rate. All ultrasound measurements used in the 
final calculations for each pig were mean values, automatically calculated in the ultrasound 
instrument, from three to five repeated selected sequential beats regarded as good quality 
measurements (174). The peak tricuspid regurgitation velocity (TR-Vmax, m/sec) was 
sampled from apical “four-chamber view” to calculate the pressure gradient between the right 
ventricle and the right atrium (mm Hg) by using the modified Bernoulli’s equation (177). 
Systolic right ventricular pressure (RVP) was calculated indirectly as the sum of central 
venous pressure and the pressure gradient between the right ventricle and the right atrium. 
Different methods for estimating pulmonary artery pressure are currently available. The 
pulmonary artery systolic pressure estimation from the peak velocity of the tricuspid 
regurgitation is evaluated to be the most precise non-invasive method (177;178).  
Tissue Doppler imaging (TDI) 
Traditionally Doppler ultrasound has been applied for measuring blood flow velocities. In 
contrast to blood flow reflecting high velocity and low amplitude Doppler signals, myocardial 
tissue movements produce low velocity and very high amplitude Doppler signals. Blood flow 
imaging applies a high-pass filter incorporated to eliminate the strong and low-frequent tissue 
signals and the gain settings are increased to amplify the signals estimating blood velocity 
(179). To display tissue velocities, the high-pass filter is bypassed and a lower gain 
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application is used to eliminate the weaker intensity blood flow signals (179). The technical 
principles and limitations of TDI are similar to those encountered with conventional Doppler 
echocardiography (179). Angle dependency is an important limitation, and angles < 16 % has 
been regarded as acceptable giving less than 20 % error (180-182). Aliasing is another well 
known phenomenon in Doppler echocardiography, and when the velocity exceeds the 
maximum detectable frequency (the Nyquist limit), the velocities appear to be transposed to 
the other end of the scale (171;182). The interplay between frame rate and temporal filtering 
must be considered, and to avoid the risk of loosing information of myocardial motion it may 
be preferred to use high frame rates and filtering (183).  
TDI was introduced as a method to quantify myocardial function in terms of tissue velocity 
(183-185).The capability to distinguish local velocities from translational motion and 
tethering effects from other regions, are however impossible using tissue velocity. Thus to 
improve the ability of TDI to measure regional function, Heimdal et al. introduced cardiac 
real time strain and strain rate as a novel extension of TDI (186). 
Strain Doppler echocardiography (SDE) 
The concept of myocardial strain was defined by Mirsky et al (187) as fractional tissue 
deformation in response to applied force (stress). In this context strain is directly related to 
myocardial fibre shortening, and represents fractional change of tissue length (change in 
length per unit length). Strain reflects deformation of myocardium and is expressed as percent 
shortening or lengthening (Lagrangian formula).  
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In general terms, if an object has an initial length L0, and after a certain time changes to the 
length L, strain is defined as
strain = ——— 
L – L0
L0
Thus strain describes the contraction/relaxation pattern in the myocardium, and both 
longitudinal and radial strain may be assessed by this Doppler technique (188). Strain 
represents a powerful non-invasive diagnostic tool to assess LV function (189). Strain has 
been shown to be superior to tissue Doppler velocity for measuring systolic function 
(190;191) and the modalities are less sensitive to segment tethering and cardiac translation 
(192). Analyses of strain appear to be less prone to noise than strain rate because integration 
from strain rate tends to minimize the influence of small random changes (193). By current 
methods SDE can only be assessed one-dimensional along the ultrasound beam. Despite the 
limitation, SDE has been reported to correlate well with 3D magnetic resonance (MR) 
findings (194) as well as to sonomicrometry in animal models (195). It has been shown that 
strain representing deformation of myocardium is load dependent and is best correlated with 
stroke volume (196) and ejection fraction (197). 
During the experiments the strain images were obtained with a frame rate varying between 
180-250 frames per second. Digital data were recorded over 3 consecutive heart cycles and 
analysed off-line. Standard apical 2-chamber and 4-chamber views and parasternal short axis 
views were used. To maintain a high frame rate without loss of lateral resolution, separate 
loops were obtained to focus on septum and lateral wall. Sample volume was set to 5 mm for 
longitudinal measurement and 2 mm for radial measurement. During off line analysis, 
longitudinal peak strain was assessed at mid anterior, posterior, lateral, and septal segments. 
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In short axis views radial peak strain values were assessed in the anterior septum and posterior 
wall segments. The strain data were calculated and averaged from all three cardiac cycles. 
The region of interest in the 2D-image was repositioned during the heart cycle by manual 
frame to frame marking to compensate for the movement of the heart. This corrected strain 
trace was used for processing. The interventricular septum is believed to be a functionally 
bilayered structure, with the presence of two radial velocity gradients within the septum, one 
on the LV side and one on the right (182;198). The sample volume was set to 2 mm, with no 
possibility to differentiate between left and right part of the septum in the newborn pig.  
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Summary of results 
Paper I
Resuscitation with 100% O2 does not protect the 
myocardium in hypoxic newborn piglets 
58 newborn pigs (12-36h) divided into a total of 6 groups (n=9/10) were exposed to 
hypoxaemia by 8% oxygen. When mean arterial blood pressure fell to 15 mmHg, or arterial 
BE d -20 mmol/L, reoxygenation was performed for 30 minutes with either 21% or 100% 
oxygen at low (PaCO2 of 2.0–3.5 kPa), normal (PaCO2 of 4.5–6.0 kPa) or elevated (PaCO2 of
8.0–9.5 kPa) carbon dioxide level. Afterwards the pigs were ventilated with 21% O2 and
normal PaCO2 for 150 minutes. Blood samples were analysed for cTnI, myoglobin, and CK-
MB at baseline and at the end of the study. CTnI increased more than 10-fold (p < 0.001) in
all the groups, with no significant difference between the groups. Myoglobin and CK-MB 
doubled in concentration. The considerable increase in cTnI indicated a substantially affected
myocardium due to severe hypoxaemia. Reoxygenation with 100% oxygen offered no
biochemical benefit over ambient air. CK-MB and myoglobin were not reliable markers of 
myocardial damage in this model of newborn pigs.  
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Paper II
Restoration of cardio-pulmonary functions with 21% vs. 
100% O2 after hypoxaemia in newborn pigs
20 newborn pigs were exposed to hypoxaemia by 8% oxygen. When mean arterial blood 
pressure fell to 15 mmHg, or arterial BE d -20 mmol/L, reoxygenation was performed  with 
either 21% (n=10) or 100% (n=10) O2 for 30 min and then ventilated with ambient air for 
another 120 minutes. Blood was analysed for cTnI, confirming a considerable myocardial 
injury with no differences between pigs reoxygenated with 21% and 100% O2. Ultrasound 
examinations of cardiac output (CO) and pulmonary artery pressure (PAP, estimated from 
tricuspid regurgitation velocity (TR-Vmax)) were performed at baseline, during hypoxaemia, 
at start of reoxygenation and during reoxygenation. TR-Vmax increased during the insult, 
returned towards baseline values during reoxygenation, with no differences between the 
groups (p=0.11). An inverse relationship was found with increasing age and TR-Vmax during 
hypoxaemia (p=0.034). CO/kg increased during early phase of hypoxaemia (p<0.001), then 
decreased. Changes in CO/kg were mainly due to changes in heart rate with no differences 
between the groups during reoxygenation (p=0.298). Global hypoxaemia affects myocardium 
and pulmonary artery pressure in newborn pigs and during this limited period of observation, 
reoxygenation with 100% showed no benefits compared to 21% O2 in normalising myocardial 
function with respect to CO and pulmonary artery pressure.
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Paper III
Increased Myocardial Matrix Metalloproteinases in 
Hypoxic Newborn Pigs during Resuscitation. Effects of 
Oxygen and Carbon Dioxide 
At the end of study referred to in paper I the pigs were given an overdose of penthobarbital, 
and the heart was immediately removed. The free wall of left and right ventricle was instantly 
frozen in liquid nitrogen. In myocardial tissue extracts, MMPs were analysed by i) gelatine 
zymography and ii) broad matrix degrading capacity (total MMP-activity). Total endogenous 
antioxidant capacity in myocardial tissue extracts was measured by the oxygen radical 
absorbance capacity (ORAC) assay. As a sign of affected myocardium MMP-2 more than 
doubled from baseline values (p<0.001), and was more pronounced in piglets reoxygenated 
with 100% than with 21% O2 (p=0.01). The ORAC value was considerably decreased 
(p<0.001), suggesting that oxidative stress may be a key player causing adverse tissue injury. 
Left ventricular (LV) total MMP-activity was increased in pigs with low PaCO2 compared to 
pigs with elevated PaCO2 (p=0.01), indicating that hyperventilation may be detrimental and 
cause more severe myocardial injury. LV total MMP-activity in pigs with elevated PaCO2 was
not different from baseline. In pigs with elevated PaCO2, total MMP-activity was more 
increased in right (RV) than in left ventricle (p<0.01). Alteration in total MMP-activity 
subsequent to hypoxaemia and resuscitation, suggests that elevated carbon dioxide (PaCO2 of
8.0–9.5 kPa) may protect LV, and contribute to a greater RV injury in newborn pigs. This 
study demonstrates the importance of resuscitation procedures, since not only oxygen supply 
but also the PaCO2-level has to be addressed to avoid additional iatrogenic tissue injury 
during resuscitation of neonatal pigs. 
41
Paper IV
Left Ventricular Longitudinal Deformation is More 
Vulnerable than Radial Deformation. A Strain Doppler 
Echocardiographic Study in Hypoxaemic Newborn Pigs 
11 newborn pigs (age 12 to 36 hours) were exposed to hypoxaemia by 8% oxygen. When 
mean arterial blood pressure fell to 15 mmHg, or arterial BE d -20 mmol/L, reoxygenation 
was performed with 21% or 100% oxygen and the pigs were observed for 150 min. Analyses 
of the two groups have so far been combined. Cardiac dysfunction during global hypoxaemia 
was assessed by strain Doppler echocardiography (SDE) which represents a powerful non-
invasive diagnostic tool to assess LV function. During hypoxaemia longitudinal strain showed 
paradoxical stretching, while radial strain continued to demonstrate thickening. In addition, 
the changes in the longitudinal myocardial contraction were heterogeneous. These findings 
suggest that longitudinal contraction may be more vulnerable to global hypoxaemia than 
radial contraction in newborn pigs. Accordingly, in cases when radial functions appear 
conserved, longitudinal strain assessments may be necessary to exclude hypoxaemic injury of 
the myocardium 
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General discussion 
In our department we have been working with brain and lung injury subsequent to 
resuscitation of newborn pigs over several years, continuously trying to improve the model 
approaching  the question whether newborn in general should be resuscitated with or without 
supplemental oxygen (199-203). Through induction of severe hypoxaemia we have aimed at 
simulating the clinical situation of intrapartum asphyxia with development of acidosis, 
resulting in increased PAP and myocardial dysfunction.  
In this thesis we approached the myocardial injury of hypoxaemia and reoxygenation by four 
different methods in a model of newborn pigs. In the first and second study we were 
evaluating the myocardial injury by troponins and echocardiography. These are global signs 
of an affected myocardium, and are methods currently used in modern neonatal care units. In 
paper III we examined the myocardial injury directly in tissue extracts, aiming to clarify the 
myocardial tissue injury emphasizing both ventilation and oxygenation. In paper IV we 
intended to focus on LV performance and the diagnostic feasibilities of SDE, as invasive data 
are not always available in a clinical practise. Strain assessments and analyses of MMPs in 
myocardial tissue are focal markers of myocardial injury. Accordingly, we have focused on 
both biochemical and functional changes in myocardium during hypoxaemia and 
reoxygenation. The study aimed at approaching the fine balance of both physiological and 
molecular biological alterations in the myocardium. The problem resolving hypoxaemia-
induced myocardial and haemodynamic changes in theses group of age necessitates 
alternative considerations.  
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The pig model 
A limitation regarding the pig model was the age of the experimental animal, as the included 
pigs were 12-36 hours of age. The animals had been adapted to extra-uterine life, and had 
already started and more or less completed the haemodynamic changes from a dominating 
high pressure RV and low pressure LV system to an adult circulatory pattern with low 
pressure RV and high pressure LV, and with no flow through the fetal shunts (68;132). 
Walthers et al found that 8 hours after birth the majority of measurable changes in 
cardiopulmonary hemodynamics have occurred in healthy infants, though there was found 
some degree of right-to-left shunting in ductus arteriosus in the neonates up to 12 hours after 
birth (45). Fugelseth et al found bidirectional shunting in approximately 50% of the patients 
with an open duct at 14 hours postnatal, and mainly left to right ductal flow by 36 hours (38). 
This may be important as we found that age was inversely correlated to pulmonary artery 
pressure as assessed by TR-Vmax. Furthermore, we observed that hypoxaemia-induced 
haemodynamic changes were tolerated for a longer time course by the youngest pigs.  
All manipulation and instrumentation (anaesthesia, surgery, hypoxaemia) were the same in 
both test animals and control animals, and care was take to minimize injury during 
procedures. The pigs went through a severe hypoxaemic insult, with grave acidosis with pH 
below 7,0 and serum-lactate 15 mmol/L (unpublished data) at start of resuscitation. The pigs 
were able to compensate with increased HR up to 270 beats per minute, before some of them 
eventually developed bradycardia (HR 35-70 beats per minute) with a severely compromised 
myocardium when resuscitation was about to start.
As demonstrated in paper IV, the restoration of myocardial function and haemodynamics are 
initiated but not completed by 2.5 hours. We would have needed a longer time of observation 
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to restore both the haemodynamic changes as well as myocardial performance assessed by 
SDE. We would also have needed either a larger experimental group or a longer period of 
observation to find out whether there would have been any differences in myocardial 
performance due to different reoxygenation regimens.  
There are notable interindividual variations amongst the pigs, implying the need of relatively 
large experimental groups as they respond differently to asphyxia and need different time 
course for restoration. This limited time course also exclude us from studying long time 
effects of hypoxaemia and reoxygenation on myocardium, which would have necessitated a 
different study design and long term survival. 
Cardiac Troponin I / MMPs 
In the experiment we used cTnI as a marker of myocardial injury before and after a 
hypoxaemic insult. In addition to cardiac Troponin I and T, it has been shown that slow 
skeletal muscle troponin I is found in neonatal myocardium up to 9 months of age (28). 
Acidosis has a negative inotropic effect, as low pH decreases the Ca2+ sensitivity to the 
troponin complex (204). During acidosis neonatal myofibrils has shown to be more resistant 
to low pH than adult myocardium (28;205). Fetal myofilaments, containing slow skeletal 
muscle troponin I are suggested to have greater maximal force, greater maximal ATPase 
activity, lower minimal ATPase activity, and greater Ca2+ sensitivity of force development 
when compared with adult troponin (206). The slow skeletal muscle troponin I is probably a 
major contributor to preserve contractility in severely acidotic neonates. 
In paper I we found that normoventilation tended to produce better myocardial outcome than 
hyperventilation and hypoventilation as assessed by cTnI. CTnI was measured in serum as a 
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global marker of myocardial injury, however, and not in myocardial tissue. In paper III total 
MMP-activity assessed as a focal marker of injury in myocardial tissue extracts made us 
conclude differently. The free wall of left and right ventricle had been analyzed separately. 
The major difference between cTnI in serum and MMP assessments in myocardial tissue 
extracts were seen in the pigs with increased PaCO2-level. These pigs had been 
normoventilated adding CO2 in the inspired gas to reflect hypoventilation. Total MMP-
activity in LV were not increased from baseline, indicating that CO2 may have a protective 
effect on LV. Contrary to the findings in LV, there were a considerably increased total MMP-
activity in RV tissue extracts, probably responsible for the increased cTnI as MMP-2 cleaves 
cTnI from the Troponin complex (156). Low pH and elevated PaCO2 may further augment the 
hypoxaemic pulmonary vascular resistance (207;208), suggesting increased RV workload due 
to an additional increase in pulmonary artery pressure at PaCO2 8.0–9.5 kPa.
Contrary to the results in paper I, in paper III we also found significant differences in 
myocardial tissue injury dependent on oxygen supply during reoxygenation subsequent to 
hypoxaemia. The highly increased MMP-2 activity in pigs reoxygenated with 100% oxygen 
indicates a more severe myocardial tissue injury compared to the pigs reoxygenated with 
ambient air. This is in agreement with a clinical study presented at Pediatric Academic 
Societies’ Annual Meeting 2005 regarding resuscitation of asphyxiated neonates (209). In this 
study the newborn resuscitated with ambient air had better outcome, lower cTnI levels, less 
pronounced and shorter-lasting oxidative stress than newborn resuscitated with 100% oxygen.
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MMPs / ORAC 
In this study, the total endogenous antioxidant capacity in myocardial tissue extracts was 
assessed by the ORAC assay. The ORAC-value was considerably decreased from baseline, 
most pronounced in pigs reoxygenated by 100% oxygen. Several studies have shown that 
during hypoxaemia/reoxygenation/reperfusion injury, oxidative stress and ROS formation 
increases MMP levels in tissues (210;211). The different outcome regarding PaCO2-level and 
ventilation were seen analysing total MMP activity which reflects the joint capacity of 
different MMPs. By measurements of total MMP activity we are not able to differentiate 
which MMPs are activated during the analysis. From other studies, however, it has been 
shown that several MMPs including MMP-1 and MMP-2, have been activated by oxidative 
stress and pro-inflammatory cytokines as TNF-Į and interleukins (49;52;75). These cytokines 
may activate leucocytes to generate ROS resulting in myocardial injury (75;77). These results 
indicate that both MMP-2 activity and total MMP activity in tissue extracts probably is 
induced by oxidative stress, which is consistent with other studies (65;76;86;211). In our 
research group, in the same pig model, we found increased MMP activity and interleukin-8 
concentration in pulmonary tissues (212). MMP activity and interlucin-8 were more 
pronounced in pigs resuscitated with 100% oxygen than in pigs resuscitated with ambient air, 
suggesting a marked proinflammatory response in pulmonary tissues. 
Haemodynamics in the newborn 
In fetal life hypoxaemia is a physiological stimulus maintaining the pulmonary vasculature 
constricted (26). In the pulmonary vasculature, increased oxygen is a powerful stimuli 
inducing vasorelaxation at birth (213). Sustained exposure to hypoxaemia leads to 
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vasoconstriction which is reversible by reoxygenation (53). The pulmonary vasculature is 
especially vulnerable to hypoxaemic stimuli during the first days of life (29;53;214). 
Accordingly, we found that increased PAP was age dependant, correlating inversely with age.
Concomitantly with the induction of hypoxaemia, systemic blood pressure (SBP) fell, while 
HR and CO/kg increased. Increased PAP or elevated PVR results in increased RV afterload. 
With elevated PAP, the septum shifts in a leftward direction, impairing LV ejection (215;216). 
Increased PAP will also reduce LV preload, further decreasing LV stroke volume. SBP and 
perfusion depend on the LV preload requiring a normal PVR to allow effective filling. The 
reduced LV preload resulting in systemic hypotension, will again affect RV function by 
reduced coronary perfusion pressure (217;218).
Neonates regulate their CO mainly by regulating heart rate, which is consistent with our 
results (29). A reduction in CO will be compensated by a redistribution of the blood flow to 
the various organs to maintain the SBP and adequate perfusion pressures to vital vascular 
beds. Changes in SBP may reflect changes in CO and/or systemic vascular resistance, and 
decreased LV afterload may for a short while improve the myocardial performance, resulting 
in reduced SBP.
In our study we found LVP changed in the same direction as CO/kg and inversely with TR-
Vmax. The considerable increase in RVP exceeding LVP may contribute in reducing 
coronary perfusion resulting in RV ischaemia, further compromising myocardium (58;218). 
Low pH and hypercapnia may aggravate hypoxic pulmonary vasoconstriction (207;208). We 
had no echocardiographic measurements assessing neither tricuspid regurgitation nor blood 
flow through the fetal shunts in the pigs ventilated with elevated CO2. Following a more 
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aggravated pulmonary vasoconstriction, however, we might have expected a greater tricuspid 
regurgitation and possibly increased ductal shunting. Severe pulmonary hypertension may 
cause bidirectional or right-to-left shunting in the ductus arteriosus, and may also be assessed 
as changed flow pattern in ductus venosus (219). 
In the pigs examined by echocardiography, only one had a persistent ductus arteriosus as we 
started the experiment. One pig reopened the ductus arteriosus during hypoxaemia, and two 
reopened the duct at the end of the reoxygenation period. All ductal shunting were left-right, 
although two pigs had a bidirectional shunt for a short period during hypoxaemia. The 
maximum systolic peak velocities were not measured as the angle errors were too large. None 
of the pigs had a pure right-left shunt, which further could have compromised the situation.  
In paper IV we focused on myocardial performance during hypoxaemia, finding a complex 
and heterogeneous systolic pattern with distinct regional differences as assessed by strain 
Doppler echocardiography. Radial systolic strains remained positive showing thickening 
during hypoxemia, but maximum values were decreased and delayed. In contrast, longitudinal 
systolic strain became positive showing a paradox lengthening in the septal and posterior 
segments. In the anterior and lateral segments, however, peak longitudinal strain values were 
decreased but remained negative. We constructed pressure-strain loops, loop area representing 
myocardial work. Counterclockwise rotation represented active work during longitudinal 
contraction, while clockwise rotation represented active work during radial contracting. 
During severe hypoxaemia the longitudinal strain-pressure loops orientation turned from 
counterclockwise to clockwise and from active to passive work in septum and posterior wall, 
which is in agreement with other studies (220;221). During severe hypoxaemia radial 
pressure-strain loops remained a clockwise rotation, indicating a still maintained active 
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contraction. This indicates that the direction of the pressure-strain loops contribute 
information regarding myocardial performance. Accordingly, longitudinal contraction may be 
more vulnerable to hypoxaemic insults, and radial contraction performing the major work 
during severe hypoxaemic conditions in newborn pigs. 
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Conclusion
1) Cardiac Troponin I is shown as a reliable blood test demonstrating myocardial injury 
in hypoxaemic newborn pigs. CK-MB and myoglobin were not reliable markers of 
myocardial damage. Reoxygenation with 100% oxygen at different PaCO2 levels 
offered no biochemical benefit over reoxygenation with ambient air. 
2) Hypoxaemia decreases cardiac output and increases pulmonary artery pressure in 
newborn pigs. Reoxygenation with 100% oxygen showed no benefit compared to 21% 
oxygen in restoring haemodynamics. 
3) Matrix metalloproteinases (MMPs) were considerably increased indicating myocardial 
tissue injury and more pronounced after reoxygenation with 100% than 21% oxygen. 
As assessed by MMP activity, hyperventilation and low PaCO2 may be detrimental to 
myocardium. Elevated PaCO2 during resuscitation may protect left ventricle and 
probably increase right ventricular injury. Antioxidant capacity was decreased 
indicating oxidative stress, but with no differences between the reoxygenation groups. 
4) Rapid changes in left ventricular performance during hypoxaemia and reoxygenation 
in newborn pigs are assessable by strain Doppler echocardiography. Longitudinal 
contraction seems to be more vulnerable to hypoxaemia than radial contraction; 
accordingly both longitudinal and radial functions have to be considered during a 
hypoxaemic injury. 
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Errata
Paper III
Results
Second column, Gelatinolytic activity in heart extracts, eighth line should read;  
“MMP-2 was significantly higher in group B than in group A (p=0.012). 
Second column, Total MMP activity, fourth line should read;
“Left ventricle total MMP-activity increased in group A1/B1 (14930.0 R.F.U. ± 922,
P = 0.003) and group A2/B2 (13634.5 R.F.U. ± 1240, P = 0.027) compared to the control  
piglets (9606.5 R.F.U. ± 1453)”. 
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